Unique interaction of scorpion toxins with the hERG channel

Journal of Molecular Recognition

Volumn 17, Issue 3, 2004, Pages 209-217

  Korolkova, Yuliya V ^a   Tseng, Gea Ny ^b   Grishin, Eugene V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

hERG K+ channel; Mutant cycle analysis; Scorpion toxins; Toxin channel interaction

Indexed keywords

BEKM 1 TOXIN; BEKM-1 TOXIN; ERG1 POTASSIUM CHANNEL; KCNH2 PROTEIN, HUMAN; POTASSIUM CHANNEL HERG; SCORPION VENOM; TOXIN; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL; CHEMISTRY; CONFERENCE PAPER; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING;

ANIMALS; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN BINDING; SCORPION VENOMS; TOXINS, BIOLOGICAL;

SCORPIONES;

EID: 2542464052     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.667     Document Type: Conference Paper

References (49)

1. Aiyar J, Withka JM, Rizzi JP, Singleton DH, Andrews GC, Lin W, Boyd J, Hanson DC, Simon M, Dethlefs B, Lee C-L, Holl JE, Gutman GA, Chandy KG. 1995. Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron 15: 1169-1181.
2. Aiyar J, Rizzi JP, Gutman GA, Chandy KG. 1996. The signature sequence of voltage-gated potassium channels projects into the external vestibule. J. Biol. Chem. 271: 31013-31016.
3. Batista CV, Gomez-Lagunas F, Rodriguez de la Vega RC, Hajdu P, Panyi G, Gaspar R, Possani LD. 2002. Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K(+)-channels with distinctly different affinities. Biochim. Biophys. Acta 1601: 123-131.
4. Brown DA, Adams PR. 1980. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 283: 673-676.
5. Castle N. 1999. Recent advances in the biology of small conductance calcium-activated potassium channels. In Perspectives in Drug Discovery and Design 15/6, Darbon H, Sabatier J (eds). Kluwer: Dordrecht; 131-154.
6. + channel localized by mutant cycle analysis. Biochemistry 37: 4407-4419.
7. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, Vega-Saenz de Miera E, Rudy B. 1999. Molecular diversity of K+ channels. Ann. NY Acad. Sci. 868: 233-285.
8. Corona M, Gurrola GB, Merino E, Cassulini RR, Valdez-Cruz NA, Garcia B, Ramirez-Dominguez ME, Coronas FI, Zamudio FZ, Wanke E, Possani LD. 2002. A large number of novel Ergtoxin-like genes and ERG K+-channels blocking peptides from scorpions of the genus Centruroides. FEBS Lett. 532: 121-126.
9. Cui M, Shen J, Briggs JM, Fu W, Wu J, Zhang Y, Luo X, Chi Z, Ji R, Jiang H, Chen K. 2002. Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J. Mol. Biol. 318: 417-428.
10. Diochot S, Loret E, Bruhn T, Beress L, Lazdunski M. 2003. APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go-related gene potassium channels. Mol. Pharmac. 64: 59-69.
11. Dun W, Jiang M, Tseng GN. 1999. Allosteric effects of mutations in the extracellular S5-P loop on the gating and ion permeation properties of the hERG potassium channel. Pflugers Arch. 439: 141-149.
12. Fan JS, Jiang M, Dun W, McDonald TV, Tseng GN. 1999. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel. Biophys. J. 76: 3124-3128.
13. Filippov AK, Kozlov SA, Pluzhnikov KA, Grishin EV, Brown DA. 1996. M-type K+ current inhibition by a toxin from the scorpion Buthus eupeus. FEBS Lett. 384: 277-280.
14. Garcia ML, Hanner M, Knaus HG, Slaughter R, Kaczorowski GJ. 1999. Scorpion toxins as tools for studying potassium channels. Meth. Enzymol. 294: 624-639.
15. Garcia ML, Gao Y, McManus OB, Kaczorowski GJ. 2001. Potassium channels: from scorpion venoms to high-resolution structure. Toxicon 39: 739-748.
16. Gross A, MacKinnon R. 1996. Agitoxin footprinting the shaker potassium channel pore. Neuron 16: 399-406.
17. Gurrola GB, Rosati B, Rocchetti M, Pimienta G, Zaza A, Arcangeli A, Olivotto M, Possani LD, Wanke E. 1999. A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom. FASEB J. 13: 953-962.
18. Hidalgo P, MacKinnon R. 1995. Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor. Science 268: 307-310.
19. Huys I, Xu CQ, Wang CZ, Vacher H, Martin-Eauclaire MF, Chi CW, Tytgat J. 2003. BmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currents. Biochem. J. 5 November (Epub ahead of print).
20. Korolkova YV, Kozlov SA, Lipkin AV, Pluzhnikov KA, Hadley JK, Filippov AK, Brown DA, Angelo K, Strobaek D, Jespersen T, Olesen SP, Jensen BS, Grishin EV. 2001. An ERG channel inhibitor from the scorpion Buthus eupeus. J. Biol. Chem. 276: 9868-9876.
21. Korolkova W, Bocharov EV, Angelo K, Maslennikov IV, Grinenko OV, Lipkin AV, Nosyreva ED, Pluzhnikov KA, Olesen SP, Arseniev AS, Grishin EV. 2002. New binding site on common molecular scaffold provides HERG channel specificity of scorpion toxin BeKm-1. J. Biol. Chem. 277: 43104-43109.
22. Korolkova Y, Zhang M, Liu J, Jiang M, Grishin E, Kellogg G, Tseng G-N. 2003. Probing the outer vestibule structure of the HERG channel using the 'mutant cycle analysis' with recombinant peptide toxins. Biophys. J. 84: 8a.
23. Li H, Fuentes-Garcia J, Towbin JA. 2000. Current concepts in long QT syndrome. Pediatr. Cardiol. 21: 542-550.
24. Meves H, Schwarz JR, Wulfsen I. 1999. Separation of M-like current and ERG current in NG108-15 cells. Br. J. Pharmac. 127: 1213-1223.
25. Miller C. 1995. The charybdotoxin family of K+ channel-blocking peptides. Neuron 15: 5-10.
26. Milnes JT, Dempsey CE, Ridley JM, Crociani O, Arcangeli A, Hancox JC, Witchel HJ. 2003. Preferential closed channel blockade of HERG potassium currents by chemically synthesized BeKm-1 scorpion toxin. FEBS Lett. 547: 20-26.
27. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z. 2002. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105: 794-799.
28. Mouhat S, Mosbah A, Visan V, Wulff H, Delepierre M, Darbon H, Grissmer S, De Waard M, Sabatier JM. 2004. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels. Biochem. J. 377: 25-36.
29. Naini AA, Miller C. 1996. A symmetry-driven search for electrostatic interaction partners in charybdotoxin and a voltage-gated K+ channel. Biochemistry 35: 6181-6187.
30. Naranjo D, Miller C. 1996. A strongly interacting pair of residues on the contact surface of charybdotoxin and a Shaker K+ channel. Neuron 16: 123-130.
31. Nastainczyk W, Meves H, Watt DD. 2002. A short-chain peptide toxin isolated from Centruroides sculpturatus scorpion venom inhibits ether-a-go-go-related gene K(+) channels. Toxicon 40: 1053-1058.
32. Pardo-Lopez L, Zhang M, Liu J, Jiang M, Possani LD, Tseng GN. 2002. Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule. J. Biol. Chem. 277: 16403-16411.
33. 2+-activated K+ channels and afterhyperpolarization currents in central neurons. J. Biol. Chem. 277: 46101-46109.
34. Picard S, Lacroix P. 2003. QT interval prolongation and cardiac risk assessment for novel drugs. Curr. Opin. Invest. Drugs 4: 303-308.
35. Possani LD, Merino E, Corona M, Bolivar F, Becerril B. 2000. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 82: 861-868.
36. Ranganathan R, Lewis JH, MacKinnon R. 1996. Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis. Neuron 16: 131-139.
37. Rauer H, Lanigan MD, Pennington MW, Aiyar J, Ghanshani S, Cahalan MD, Norton RS, Chandy KG. 2000. Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca(2+)-activated over voltage-gated K(+) channels. J. Biol. Chem. 275: 1201-1208.
38. Roden DM, Balser JR, George AL Jr, Anderson ME. 2002. Cardiac ion channels. A. Rev. Physiol. 64: 431-475.
39. Rodriguez de la Vega RC, Merino E, Becerril B, Possani LD. 2003. Novel interactions between K+ channels and scorpion toxins. Trends Pharmac. Sci. 24: 222-227.
40. Rowan EG, Harvey AL. 1996. Toxins affecting K+ channels. Braz. J. Med. Biol. Res. 29: 1765-1780.
41. Sansom MS, Shrivastava IH, Bright JN, Tate J, Capener CE, Biggin PC. 2002. Potassium channels: structures, models, simulations. Biochim. Biophys. Acta 1565: 294-307.
42. Schreiber G, Fersht AR. 1995. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J. Mol. Biol. 248: 478-486.
43. Selyanko AA, Hadley JK, Wood IC, Abogadie FC, Delmas P, Buckley NJ, London B, Brown DA. 1999. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. J. Neurosci. 19: 7742-7756.
44. Stocker M, Miller C. 1994. Electrostatic distance geometry in a K+ channel vestibule. Proc. Natl Acad. Sci. USA 91: 9509-9513.
45. Tenenholz TC, Klenk KC, Matteson DR, Blaustein MP, Weber DJ. 2000. Structural determinants of scorpion toxin affinity: the charybdotoxin (alpha-KTX) family of K(+)-channel blocking peptides. Rev. Physiol. Biochem. Pharmac. 140: 135-185.
46. Torres AM, Bansal P, Alewood PF, Bursill JA, Kuchel PW, Vandenberg JI. 2003. Solution structure of CnErg1 (Ergtoxin), a HERG specific scorpion toxin. FEBS Lett. 539: 138-142.
47. Tseng GN. 2001. I(Kr): the hERG channel. J. Mol. Cell Cardiol. 33: 835-849.
48. Xu CQ, Zhu SY, Chi CW, Tytgat J. 2003. Turret and pore block of K+ channels: what is the difference? Trends Pharmac. Sci. 24: 446-448.
49. Zhang M, Korolkova YV, Liu J, Jiang M, Grishin EV, Tseng GN. 2003. BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1. Biophys. J. 84: 3022-3036.